Benzylhydrazine

Benzylhydrazine

SCHEMBL7876917

CCOC(=O)CNN.NNCc1ccccc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPID Q08752 3/20 0.64
IDO1 P14902 1/20 0.53
MAPT P10636 3/20 0.52
CYP3A4 P08684 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
PPIB P23284 1/20 0.50
PPIA P62937 1/20 0.50
PPIG Q13427 1/20 0.50
LTA4H P09960 4/20 0.48
NAMPT P43490 1/20 0.47
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
TSHR P16473 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP1A2 P05177 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL75205 0.82 PPID (0.69) PPIDMAPTSMN1; SMN2PPIBPPIA
Hydrochloric Acid SCHEMBL3926946 0.81 PPID (0.68) PPIDMAPTSMN1; SMN2PPIBPPIA
SCHEMBL182292 0.79
SCHEMBL1690706 0.78 ALDH1A1 (0.61) MEN1KMT2A
SCHEMBL12559711 0.78 PPID (0.64) PPIDMAPTSMN1; SMN2PPIBPPIA
SCHEMBL12643825 0.78 PPID (1.00) PPIDMAPTSMN1; SMN2PPIBPPIA
Methylamine SCHEMBL8528191 0.78 PPID (0.91) PPIDMAPTSMN1; SMN2PPIBPPIA
Benzylhydrazine SCHEMBL11719108 0.77 IDO1 (0.74) IDO1MAPTCYP3A4SMN1; SMN2CYP2D6
Benzylhydrazine SCHEMBL31491980 0.77 IDO1 (0.81) IDO1MAPTCYP3A4SMN1; SMN2CYP2D6
Hydrochloric Acid SCHEMBL702983 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0819000-A4 NODULISPORIC ACID DERIVATIVES MERCK & CO INC (US) 2001-04-11 EP disclosed
EP-0819000-A1 NODULISPORIC ACID DERIVATIVES Merck & Co., Inc. (US) 1998-01-21 EP disclosed